Delian Capital
59
8M
55
4.54
12
0.07
2
- Areas of investment
Summary
In 2011 was created Delian Capital, which is appeared as VC. The main department of described VC is located in the Beijing. The venture was found in Asia in China.
The fund has specific favorite in a number of founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline HiFiBiO, MicuRx Pharmaceuticals, Panorama Medicine Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Energy, Biopharma.
The top activity for fund was in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars. The real fund results show that this VC is 22 percentage points more often commits exit comparing to other companies. The fund is generally included in 2-6 deals every year.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Delian Capital, startups are often financed by ZhenFund, Nest.Bio Ventures, Morningside Group. The meaningful sponsors for the fund in investment in the same round are ZhenFund, Wooshin Venture Investment Corp., WI Harper Group. In the next rounds fund is usually obtained by Weihe Investment, Jinpengjia Holdings, Guangzhou Yihe Investment.
Investments analytics
Analytics
- Total investments
- 59
- Lead investments
- 12
- Exits
- 2
- Rounds per year
- 4.54
- Follow on index
- 0.07
- Investments by industry
- Biotechnology (18)
- Health Care (15)
- Manufacturing (12)
- Semiconductor (7)
- Therapeutics (6) Show 71 more
- Investments by region
-
- China (46)
- United States (5)
- France (1)
- Singapore (1)
- United Kingdom (1)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.78
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Akaso Bio | 02 Apr 2024 | Biotechnology | Seed | Jiangsu, Suzhou, China | |
| Zhongqu Technology | 01 Jan 2016 | Information Technology, 3D Technology | Seed | Beijing, Dongcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.